Label: BETADINE- povidone-iodine solution

  • NDC Code(s): 0065-0411-30
  • Packager: Alcon Laboratories, Inc.
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Drug Application

Drug Label Information

Updated June 29, 2022

If you are a consumer or patient please visit this version.

  • DESCRIPTION

    DESCRIPTION: Povidone-Iodine is a broad-spectrum microbicide with the chemical formulas: 2-pyrrolidinone, 1- ethenyl-, homopolymer, compound with iodine; 1-vinyl-2-pyrrolidinone polymer, compound with iodine.
    The structural formula is as follows:

    chemical

    BETADINE* 5% Sterile Ophthalmic Prep Solution contains 5% povidone-iodine (0.5% available iodine) as a sterile dark brown solution stabilized by glycerin. Inactive Ingredients: purified water, citric acid, glycerin, nonoxynol-9, sodium chloride, sodium hydroxide, and dibasic sodium phosphate.

  • CLINICAL PHARMACOLOGY

    CLINICAL PHARMACOLOGY: A placebo-controlled study in 38 normal volunteers yielded data for 36 subjects who showed a mean log10 reduction of 3.05 log10 units in total aerobes at 10 minutes following prepping the skin with BETADINE* 5% Sterile Ophthalmic Prep Solution compared with reduction of 1.58 log10 units after prepping with vehicle free of the iodine complex. This placebo-controlled study indicates a mean log10 reduction by the iodine complex compared with the control solution of 1.47 log10 units at 10 minutes and 1.79 log10 units at 45 minutes. The base-line mean aerobic bacterial count was 7,586 organisms/cm2.

  • INDICATIONS & USAGE

    INDICATIONS AND USAGE: BETADINE* 5% Sterile Ophthalmic Prep Solution for the eye is indicated for prepping of the periocular region (lids, brow, and cheek) and irrigation of the ocular surface (cornea, conjunctiva, and palpebral fornices).

  • CONTRAINDICATIONS

    CONTRAINDICATIONS: Do not use on individuals known to be sensitive to iodine, or other components of this product.

  • WARNINGS

    WARNINGS: FOR EXTERNAL USE ONLY. NOT FOR INTRAOCULAR INJECTION OR IRRIGATION.

  • PRECAUTIONS:

    General: No studies are available in patients with thyroid disorders; therefore, caution is advised in using BETADINE* 5% Sterile Ophthalmic Prep Solution in these patients due to the possibility of iodine absorption.

    Carcinogenesis, Mutagenesis, Impairment of Fertility: No long term studies in animals have been performed to evaluate the carcinogenic or mutagenic potential of povidone-iodine. One report of the mutagenic potential of povidone-iodine indicated that it was positive in a modification of the Ames S. typhimurium model, but these results could not be reproduced by another researcher. Another test using mouse lymphoma and Balb/3T3 cells showed that povidone-iodine has no significant mutagenic or transformation capabilities. Other data indicated that it does not produce mutagenic effects in mice or hamsters according to the dominant lethal test, micronucleus test, and chromosome analysis.

    Pregnancy: Animal reproduction studies have not been conducted with BETADINE* 5% Sterile Ophthalmic Prep Solution. It is also not known whether BETADINE* 5% Sterile Ophthalmic Prep Solution can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. BETADINE* 5% Sterile Ophthalmic Prep Solution should only be used on a pregnant woman if clearly needed.

    Nursing Mothers: Because of the potential for serious adverse reactions in nursing infants from BETADINE* 5% Sterile Ophthalmic Prep Solution, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

  • PEDIATRIC USE

    Pediatric Use: Safety and effectiveness in pediatric patients have not been established.

  • GERIATRIC USE

    Geriatric Use: No overall differences in safety or effectiveness have been observed between elderly and younger patients.

  • ADVERSE REACTIONS

    ADVERSE REACTIONS: Local sensitivity has been exhibited by some individuals to povidone-iodine ophthalmic solution.

  • DOSAGE & ADMINISTRATION

    DOSAGE AND ADMINISTRATION: While the inner surface and contents of the immediate container (i.e. bottle) are sterile, the outer surface of the bottle is not sterile. The use of the bottle in a sterile field should be avoided. BETADINE* 5% Sterile Ophthalmic Prep Solution is used as follows:

    BETADINE* 5% Sterile Ophthalmic Prep Solution is used as follows:

    1. Make sure container is intact before use. To open, COMPLETELY TWIST OFF TAB, do not pull off.
    2. Gently pour entire contents of bottle into a sterile prep cup. Saturate sterile cotton-tipped applicator to prep lashes and lid margins using one or more applicators per lid; repeat once.
    3. Saturate sterile prep sponge or other suitable material to prep lids, brow and cheek in a circular ever-expanding fashion until the entire field is covered; repeat prep three (3) times.
    4. While separating the lids, irrigate the cornea, conjunctiva and palpebral fornices with BETADINE* 5% Sterile Ophthalmic Prep Solution using a sterile bulb syringe.
    5. After the BETADINE* 5% Sterile Ophthalmic Prep Solution has been left in contact for two minutes, sterile saline solution in a bulb syringe should be used to flush the residual prep solution from the cornea, conjunctiva, and the palpebral fornices.
  • HOW SUPPLIED

    HOW SUPPLIED: BETADINE* 5% Sterile Ophthalmic Prep Solution is packaged under sterile conditions, and supplied in 1 fl oz (30 mL) form sealed blue HDPE bottles. Twenty-four (24) bottles are packed in each shipper.

    NDC 0065-0411-30

    Store at 15°C to 25°C (59°F-77°F).

    Rx Only

    Single-use only

    @2021 Alcon Inc.

    Alcon
    Manufactured for:
    Alcon Laboratories, Inc.
    6201 South Freeway
    Fort Worth, TX 76134

    Manufactured by:
    Woodstock Sterile Solutions, Inc.
    Woodstock, IL 60098

    *BETADINE is a registered trademark of Purdue Products L.P.

    STW-AC6024-642R01

           

  • Principal Display Panel

    NDC 0065-0411-30

    Betadine* 5%
    Sterile Ophthalmic Prep Solution
    (povidone-iodine
    ophthalmic solution)


    For Pre-Operative Prep and
    Irrigation of the Ocular and
    Periocular Surfaces

    Flush eye thoroughly with
    sterile saline solution after
    each use.


    Rx Only

    1 Fl. Oz. (30 mL)

    Alcon

    Indications:
    For prepping of the periocular
    region (lids, brow, and cheek)
    and irrigation of the ocular
    surface (cornea, conjunctiva,
    and palpebral fornices).

    Contraindications:
    Do not use on individuals
    known to be sensitive to iodine
    or other components of this
    product.

    Warning:
    For external use only.
    NOT for intraocular injection or
    irrigation.

    Read package insert for full use
    and directions and precautions.

    Storage:
    15°- 25°C (59°- 77°F).

    Active Ingredient: povidone-iodine 5%
    (0.5% available iodine).

    Inactive Ingredients:
    purified water, citric acid, dibasic sodium
    phosphate, glycerin, nonoxynol-9, sodium
    chloride, sodium hydroxide.

    Single use only.

    Manufactured for:
    Alcon Laboratories, Inc.
    Fort Worth, Texas 76134

    Manufactured by:
    Woodstock Sterile Solutions
    Woodstock, IL 60098

    *BETADINE Reg. TM of Purdue Products L.P.

    Alcon
    Alcon Laboratories, Inc.
    6201 South Freeway
    Fort Worth, Texas 76134

    9008803-0515

    carton

    NDC 0065-0411-30

    Betadine* 5%
    Sterile Ophthalmic Prep Solution
    (povidone-iodine ophthalmic solution)

    For Pre-Operative Prep and Irrigation of the Ocular and Periocular Surfaces

    Flush eye thoroughly with sterile saline solution after each use.

    Rx Only

    1 Fl. Oz. (30 mL)

    Alcon®
    a Novartis company

    Indications:
    For prepping of the periocular region (lids, brow, and cheek) and irrigation of the ocular surface (cornea, conjunctiva, and palpebral fornices).

    Contraindications:
    Do not use on individuals known to be sensitive to iodine or other components of this product.

    Warning:
    For external use only.
    NOT for intraocular injection or irrigation.

    Read package insert for full use and directions and precautions.

    Storage:
    15°- 25°C (59°- 77°F).

    ©2014 Novartis

    Active Ingredient: povidone-iodine 5% (0.5% available iodine).

    Inactive Ingredients: purified water, citric acid, dibasic sodium phosphate, glycerin, nonoxynol-9, sodium chloride, sodium hydroxide.

    Single use only.

    Manufactured for:
    Alcon Laboratories, Inc.
    Fort Worth, Texas 76134

    Manufactured by:
    Catalent Pharma Solutions, LLC
    Woodstock, IL 60098

    *BETADINE Reg. TM of Purdue Products L.P.

    Alcon®
    Alcon Laboratories, Inc.
    6201 South Freeway
    Fort Worth, Texas 76134

    9008803-0514

    carton

    Rx only  NDC 0065-0411-30

    Betadine*

    5% Sterile
    Ophthalmic Prep Solution
    (povidone-iodine
    ophthalmic solution)
    (0.5% available iodine)

    1 fl. oz. (30mL)

    SINGLE USE ONLY

    See package insert.

    Alcon
    Mfd. for
    Alcon Laboratories, Inc.
    Fort Worth, Texas 76134 USA

    *BETADINE Reg. TM of Purdue Products L.P.

    H12639-0515

    Label

    Rx only  NDC 0065-0411-30

    Betadine®

    5% Sterile
    Ophthalmic Prep Solution
    (povidone-iodine
    ophthalmic solution)
    (0.5% available iodine)

    1 fl. oz. (30mL)

    SINGLE USE ONLY

    See package insert.

    Alcon
    Mfd. for
    Alcon Laboratories, Inc.
    Fort Worth, Texas 76134 USA

    H12639-0514

    label
  • INGREDIENTS AND APPEARANCE
    BETADINE 
    povidone-iodine solution
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0065-0411
    Route of AdministrationOPHTHALMIC
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    POVIDONE-IODINE (UNII: 85H0HZU99M) (IODINE - UNII:9679TC07X4) IODINE5 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    NONOXYNOL-9 (UNII: 48Q180SH9T)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    SODIUM PHOSPHATE, DIBASIC (UNII: GR686LBA74)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0065-0411-301 in 1 CARTON04/01/2000
    130 mL in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NDANDA01863404/01/2000
    Labeler - Alcon Laboratories, Inc. (008018525)
    Registrant - Alcon Laboratories, Inc. (008018525)
    Establishment
    NameAddressID/FEIBusiness Operations
    Woodstock Sterile Solutions, Inc.117895702manufacture(0065-0411)